BiotechTube
Home/Pulmocide/Jennifer Giottonini Cayer
JG

Jennifer Giottonini Cayer

Chief Business Officer and Head of Corporate Development

Pulmocide

Therapeutic Areas

Infectious DiseasePulmonology

Pulmocide Pipeline

DrugIndicationPhase
Opelconazole (PC945)Invasive Pulmonary Aspergillosis (refractory to standard care)Phase 3

Leadership Team at Pulmocide

DB
Dan Burgess
Chairman and Chief Executive Officer
DP
Dr. Pete Strong
Chief Scientific Officer and Cofounder
DL
Dr. Lance Berman
Chief Medical Officer
MD
Matt Dallas
Chief Financial Officer
View full Pulmocide profile